Pharmaceutical

Filter

Current filters:

None

Popular Filters

151 to 175 of 7227 results

Novartis' Japan unit faces 15-day suspension over trial data manipulation

Novartis' Japan unit faces 15-day suspension over trial data manipulation

04-02-2015

The Japanese unit of Swiss drug major Novartis is facing suspension following allegations of data manipulation…

DiovanHematologyJapanLegalNovartis PharmaceuticalsOncologyPharmaceuticalRegulation

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

04-02-2015

US drugmaker Isis Pharmaceuticals has announced top-line results from a Phase II study of ISIS-PTP1BRx…

DiabetesIsis PharmaceuticalsPharmaceuticalResearchUSA

Bleaker future for men with prostate cancer in England

04-02-2015

Today marks World Cancer Day, which this year focuses on “achieving treatment for all.” However,…

FinancialHealthcareJevtanaOncologyPharmaceuticalSanofiUK

Sanofi and MannKind's Afrezza now available in the USA

Sanofi and MannKind's Afrezza now available in the USA

03-02-2015

The only inhaled insulin Afrezza (human insulin) Inhalation Powder, developed by French drug major Sanofi…

AfrezzaDiabetesMannKindMarkets & MarketingPharmaceuticalSanofiUSA

Chugai to expand Singapore R&D unit with $476 million investment

03-02-2015

Japan's Chugai Pharmaceutical, which is majority owned by Swiss pharma giant Roche, plans to invest $476…

Chugai PharmaceuticalFinancialPharmaceuticalResearchRocheSingapore

Arena and Ildong receive marketing authorization for obesity drug Belviq in South Korea

Arena and Ildong receive marketing authorization for obesity drug Belviq in South Korea

03-02-2015

US biopharma company Arena Pharmaceuticals has received marketing authorization in South Korea for Belviq…

Arena PharmaceuticalsBelviqIldong PharmaMetabolicsPharmaceuticalRegulation

US FDA seeks 9% budget hike to $4.9 billion for FY 2016

US FDA seeks 9% budget hike to $4.9 billion for FY 2016

03-02-2015

The US Food and Drug Administration is requesting a budget of $4.9 billion to protect and promote the…

FinancialPharmaceuticalRegulationUSA

Ipsen reports strong performance by specialty care and solid overall growth for 2014

Ipsen reports strong performance by specialty care and solid overall growth for 2014

03-02-2015

French drugmaker Ipsen has reported solid growth for 2014, driven by good performance in its specialty…

DecapeptylDysportFinancialFranceIpsenPharmaceuticalSomatuline

Sparse pipeline for acromegaly and gigantism treatment limiting market growth

03-02-2015

The acromegaly and gigantism treatment market will expand at a modest compound annual growth rate (CAGR)…

EuropeMarkets & MarketingMetabolicsNovartisPfizerPharmaceuticalSandostatin LARSigniforSomavertUSA

US government seeks to negotiate Medicare prices of high-cost medicines

US government seeks to negotiate Medicare prices of high-cost medicines

03-02-2015

The Obama Administration wants to win the authority to negotiate over the prices of specialty drugs for…

FinancialPatentsPharmaceuticalPoliticsPricingUSA

FDA approves Boehringer Ingelheim and Eli Lilly's Glyxambi for type 2 diabetes

FDA approves Boehringer Ingelheim and Eli Lilly's Glyxambi for type 2 diabetes

02-02-2015

The US Food and Drug Administration has approved Glyxambi (empagliflozin/linagliptin) tablets from German…

Boehringer IngelheimDiabetesEli LillyGlyxambiPharmaceuticalRegulation

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

SOBI granted marketing authorization for Xiapex in Peyronie's disease in the EU

02-02-2015

Nordic biotech firm Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Commission…

Men's HealthPharmaceuticalRegulationSobiXiaflexXiapex

Helsinn grants Stendhal rights to NEPA in several Latin America countries

02-02-2015

Family-run Swiss oncology specialist Helsinn has granted exclusive rights to Mexico-based Especificos…

AkynzeoEisaiHelsinnLicensingNEPAnetupitantOncologypalonosetronPharmaceuticalSouth AmericaStendhal

Santhera expands senior management team with several appointments

Santhera expands senior management team with several appointments

02-02-2015

Swiss pharma company Santhera has expanded its leadership team, appointing existing senior staff members…

BoardroomPharmaceuticalSantheraSanthera PharmaceuticalsSwitzerland

Merck transfers diabetes and thyroid business from Takeda to its own operations in Russia

Merck transfers diabetes and thyroid business from Takeda to its own operations in Russia

02-02-2015

Germany’s Merck KGaA has transferred responsibility for its diabetes and thyroid portfolio from marketing…

DiabetesMarkets & MarketingMerck KGaAMerck SeronoPharmaceuticalProductionRussia

FDA approves Alcon's Pazeo for ocular allergy itch relief

FDA approves Alcon's Pazeo for ocular allergy itch relief

02-02-2015

The US Food and Drug Administration has approved Pazeo (olopatadine hydrochloride ophthalmic solution)…

AlconHealthHealth Medical PharmaNovartisOlopatadine hydrochlorideOphthalmicsPharmaceuticalUSA

Obama’s $215 million Precision Medicine Initiative launched

Obama’s $215 million Precision Medicine Initiative launched

02-02-2015

A new Precision Medicine Initiative will revolutionize personalized medicine in the USA, helped by voluntary…

HealthcarePharmaceuticalResearchUnited StatesUSA

FDA approves Bristol-Myers Squibb's Evotaz in HIV-1

FDA approves Bristol-Myers Squibb's Evotaz in HIV-1

02-02-2015

US drug major Bristol-Myers Squibb has received approval from the US Food and Drug Administration for…

Anti-viralsBristol-Myers SquibbEvotazPharmaceuticalRegulation

Russia imposes restrictions on purchases of imported drugs for state needs

02-02-2015

Russia plans to impose restrictions on the purchases of imported drugs for state needs, to index prices…

Markets & MarketingPharmaceuticalPricingRussia

Single state body for drug pricing and turnover control soon be established in Ukraine

Single state body for drug pricing and turnover control soon be established in Ukraine

02-02-2015

A single state body for the control of pricing and the turnover of drugs will soon be established in…

PharmaceuticalPricingRegulationSlavicUkraine

Shire’s Vyvanse first FDA-approved drug for binge eating

Shire’s Vyvanse first FDA-approved drug for binge eating

31-01-2015

The US Food and Drug Administration on Friday approved UK drugmaker Shire’s Vyvanse (lisdexamfetamine…

NeurologicalPharmaceuticalRegulationShireUSAVyvanse

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

AbbVie fourth-qtr beats forecasts, but posts Shire-associated $810 million loss

31-01-2015

US drugmaker AbbVie on Friday announced financial results for the fourth quarter and full year 2014,…

AbbVieAnti-Arthritics/RheumaticsAnti-viralsFinancialHumiraPharmaceuticalViekira Pak

151 to 175 of 7227 results

COMPANY SPOTLIGHT

Menarini

Back to top